Rescuing the last-line therapy colistin against Gram-negative 'superbugs': increasing the therapeutic index by attenuation of nephrotoxicity

  • Li, Jian (Primary Chief Investigator (PCI))
  • Hill, Prue A. (Chief Investigator (CI))
  • Nation, Roger (Chief Investigator (CI))
  • Velkov, Tony (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/01/1231/12/14

Funding

  • National Health and Medical Research Council (NHMRC) (Australia): AUD481,300.00